WeVote
Log In

Bill

Bill

HF 1103

Medication repository program procedures modified, and money appropriated.

2025-2026 Regular Session Introduced by Kristin Bahner and 7 co-sponsors

Modifies Minnesota medication repository program procedures and authorizes state funding to implement safer collection, storage, distribution, and oversight.

Introduction and first reading, referred to Health Finance and Policy
#healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · HF 1103

Summary of HF 1103 — Medication repository program procedures modified, and money appropriated

Note: The available information provided with the bill is limited. The summary below reflects what is publicly known from the bill’s title, status, and introductory actions. The exact provisions, dollar amounts, and detailed changes will be clear when the full text is released and analyzed.

Quick overview

  • Bill number: HF 1103
  • Title: Medication repository program procedures modified, and money appropriated
  • Purpose (as inferred from title): To modify how the medication repository program operates and to authorize state funding to support those modifications.
  • Status: Introduction and first reading; referred to the Health Finance and Policy committee
  • Introduced: February 19, 2025
  • Related bill: SF 1785 (companion)

What the bill aims to do (inferred from the title)

  • Modify procedures for Minnesota’s medication repository program. This likely involves changes to:
    • How medications are collected, stored, tested for safety and quality, and distributed.
    • Eligibility criteria for participating entities (e.g., pharmacies, hospitals, clinics) and for recipients.
    • Oversight, compliance, and reporting requirements.
    • Standards for donors, chain of custody, and patient safety measures.
  • Provide a monetary appropriation to fund these modifications, indicating a fiscal component to support implementation, administration, or expansion of the program.

Key provisions and changes (illustrative; exact provisions pending full text)

  • Procedural changes to the medication repository program (specifics to be determined in the bill text).
  • Authorization of state funds to support the program’s modified operations.
  • Potential adjustments to governance, oversight, and performance reporting related to repository activities.
  • Any associated administrative or regulatory changes needed to implement the modifications.

Who would be affected

  • State agencies and program administrators responsible for the medication repository program.
  • Participating healthcare providers, pharmacies, and hospitals that collect, store, or dispense repository medications.
  • Individuals and communities who benefit from access to safe, donated medications.
  • Donors who contribute medications, subject to new or revised procedures and safeguards.

Fiscal and timing considerations

  • The bill includes an appropriation to fund the modified program.
  • Specific appropriation amounts, funding sources, and fiscal impact are not yet available in the summary and will be detailed in the bill text and fiscal note.
  • Timeline: Introduced February 19, 2025; currently at the first-reading stage and referred to Health Finance and Policy. If advanced, it would proceed through committee hearings, potential amendments, and floor votes in the usual order.

Related process and context

  • Companion bill: SF 1785 (indicating parallel consideration in the Senate).
  • Next steps: Review the full bill text for precise provisions, definitions, and financial detail; monitor committee hearings in Health Finance and Policy; watch for amendments or sponsor/testimony.

Where to read the full bill

  • To obtain the exact legislative language, fiscal impact, and any amendments, check the Minnesota Legislature’s website for HF 1103 and the companion SF 1785, under the 2025 session.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.